RT BrianEMcGrath (@BrianEMcGrath)Metcalfe’s Law is the idea that the value of a network grows exponentially as more people connect to it.It’s not just about technology. It’s about how learning works too.What makes @RealVision different is that it’s not a solo journey. When you engage with other thinkers, the value of every insight compounds.That’s how intelligence really scales — not through algorithms, but through people.#Exponentialist1/2 ...

Core Thesis - Hims & Hers Health, Inc. is evolving from a telehealth company into an AI-powered, data-driven healthcare network, disrupting traditional healthcare models and creating a reinforcing network effect [2][3][4] Company Evolution - The company aggregates structured data from provider-patient interactions, improving outcomes and enabling smarter decision-making for healthcare providers [2][3] - Hims aims to automate processes through a unified intelligence platform, enhancing the effectiveness of doctors within its network [3] Network Effects - As more patients use the platform, better insights are generated, attracting more providers and strengthening Hims' competitive advantage [3] - Currently, Hims has around 1,500 providers, representing only 0.14% of the U.S. total, indicating significant growth potential as it reaches critical mass [3] Engagement and Strategy - Hims is deepening user engagement through a longevity strategy that includes lab testing, compounding, and proactive care under a membership model [4] - Recent acquisitions, such as a blood testing lab, support vertical integration and enhance user trust and engagement [4] Market Position and Growth - The company is experiencing surging subscription growth and expanding its international reach, positioning itself to potentially dominate the preventive, data-driven healthcare market [4] - If network effects fully materialize, Hims could transform into a trillion-dollar longevity platform [4] Financial Performance - The stock price of Hims & Hers Health, Inc. was $59.15 as of October 16th, with trailing and forward P/E ratios of 73.25 and 81.30 respectively [1] - The company's stock has appreciated approximately 13% since previous bullish coverage, indicating positive market sentiment [5]

Core Insights - The focus is shifting towards companies with depressed share prices, aiming for potential turnaround gains rather than investing in high-performing stocks [2] - Etsy's stock has plummeted 76% from its peak, raising questions about its future growth potential [3] Company Performance - Etsy experienced significant revenue growth during the pandemic, with a 111% increase in 2020 and a 35% increase in 2021, driven by an expanding user base and gross merchandise sales (GMS) [3] - In the second quarter of the current year, Etsy's GMS was $2.8 billion, which is 8% lower than the same period in 2021, indicating a failure to maintain growth despite a generally healthy economic backdrop [4] - The company's performance is closely tied to consumer spending trends, with discretionary goods sales being affected during economic downturns, highlighting its cyclical nature [5] Market Position - Despite challenges, Etsy has carved out a niche in the e-commerce market, focusing on differentiated merchandise that sets it apart from larger competitors like Amazon and Walmart [6] - Etsy boasts 93.3 million active buyers and 8.1 million active sellers, both significantly higher than pre-pandemic levels in 2019, indicating a strong user base [6] - The company benefits from a network effect that supports its competitive position, suggesting that valuation expansion and higher revenue could drive share price recovery [7]

Core Thesis - Tradeweb Markets Inc. is positioned as a leading global operator of electronic marketplaces, benefiting from the ongoing electronification of fixed-income and derivatives trading [2][4] Financial Performance - The company has achieved nearly 18% annual revenue growth from 2020 to 2024, with projected revenues of $1.73 billion in 2024 [2] - Tradeweb's net income reached $502 million in 2024, with earnings per share (EPS) compounding at over 26% annually since 2020 [3] - The company maintains a strong balance sheet with over $1.6 billion in net cash and negligible debt, supporting acquisitions and shareholder returns [3] Competitive Advantage - Tradeweb's competitive moat is characterized by a powerful network effect that attracts dealers and asset managers, creating a cycle of liquidity that is hard to replicate [4] - The company has developed a diversified platform across various financial products, enhancing its ecosystem and cross-selling opportunities [4] Valuation and Investment Thesis - Despite trading at a premium valuation compared to peers, this is justified by superior growth, operating leverage, and sustainable returns on capital [5] - A discounted cash flow (DCF) analysis suggests an intrinsic value of approximately $125 per share, indicating modest near-term upside but a compelling long-term investment opportunity with a projected 20%+ five-year internal rate of return (IRR) [6] Strategic Initiatives - Tradeweb's strategic initiatives include expansion into credit, portfolio trading, and international markets, with international revenues growing over 36% in 2024 [4]

RT Token Terminal 📊 (@tokenterminal)L2s expand @ethereum's reach & network effectDaily transactions per second for Ethereum L1 & L2s https://t.co/ze5QnTRrOw ...

Ethereum Layer 2 Scaling Solutions - Ethereum Layer 2 扩展了以太坊的覆盖范围和网络效应 [1] - 以太坊 Layer 1 和 Layer 2 的每日交易量 (TPS) 数据可用 [1]

Group 1: Company Performance - Netflix's Q2 revenue increased by 15.9% year over year to $11.1 billion, surpassing its guidance of $11.0 billion [3] - The company's earnings per share (EPS) of $7.19 exceeded projections of $7.03, reflecting a 47% growth compared to the previous year [3] - Free cash flow surged almost 87% year over year, indicating strong financial health [3] Group 2: Subscriber Growth and Market Position - Despite recent price increases in the U.S. and other markets, Netflix continues to attract new subscribers, demonstrating strong brand loyalty and competitive pricing power [5] - For Q3, Netflix is guiding for year-over-year revenue and EPS growth of 17% and 27%, respectively, with an increased full-year revenue outlook of $44.8 billion to $45.2 billion [6] - The company's ability to grow its subscriber base while raising prices suggests that customers are not highly price sensitive, indicating resilience in tougher economic conditions [9] Group 3: Competitive Advantages - Netflix's extensive ecosystem of viewers allows it to leverage data for content production, enhancing viewer engagement and driving subscriber growth through network effects [7] - The introduction of a low-price, ad-supported tier and scaling of its advertising business demonstrates Netflix's adaptability in a changing streaming landscape [8] - The shift from cable to streaming presents a long-term opportunity for Netflix as the cable market continues to shrink [11] Group 4: Market Valuation - Netflix's forward price-to-earnings ratio is just under 45, significantly higher than the communication services sector average of 19.9, reflecting its market leadership and growth potential [11][12] - Despite potential short-term volatility, the long-term outlook remains positive for investors considering holding Netflix stock for five to ten years [12]

Core Insights - Visa is a dominant player in the financial services industry, operating a leading payments platform that connects consumers, banks, and merchants globally [1][2] - Despite trading near all-time highs, Visa is considered an outstanding company worthy of investment [2] Competitive Position - In fiscal 2024, Visa processed 233.8 billion transactions valued at $15.7 trillion, with 4.8 billion active cards accepted at 150 million merchants worldwide, showcasing its unmatched scale and competitive strength [4] - The company benefits from a powerful network effect, where an increase in merchants accepting Visa enhances the card's value, and more cardholders create additional sales opportunities for merchants [5] Market Threats - The introduction of stablecoins through the Genius Act raises concerns about potential competition for Visa's business model, but current conditions do not warrant significant concern [6] - While favorable legislation may encourage merchants to explore stablecoins, consumer loyalty to credit cards and their associated perks suggests that Visa's entrenched position in the economy is difficult to disrupt [7]

Financial Data and Key Metrics Changes - Adjusted EBITDA for the quarter exceeded $1,000,000,000, significantly beating expectations, despite a modestly negative system-wide RevPAR [6][19] - Adjusted EPS also exceeded expectations, with diluted earnings per share adjusted for special items at $2.20 [20] - Year-to-date, the company returned $1,700,000,000 to shareholders through buybacks and dividends, on track to return approximately $3,300,000,000 for the full year [7][26] Business Line Data and Key Metrics Changes - System-wide RevPAR decreased by 50 basis points year-over-year, driven by declines in occupancy and modest rate growth [19] - Leisure transient RevPAR grew by 1%, while business transient RevPAR decreased by 2% due to various factors including government spending declines and broader economic uncertainty [8][19] - Group RevPAR was roughly flat, with favorable trends in company meetings offset by soft convention business [9] Market Data and Key Metrics Changes - U.S. RevPAR decreased by 1.5%, largely due to pressure across business transient and group segments [20] - In the Americas outside the U.S., RevPAR increased by 3.8%, driven by strength in the luxury and lifestyle portfolio [21] - Middle East and Africa region saw a 10.3% increase in RevPAR, while Asia Pacific's RevPAR was up 0.3%, with APAC ex-China increasing by 5.2% [22][23] Company Strategy and Development Direction - The company opened 221 hotels totaling over 26,000 rooms, representing a 52% year-over-year increase, achieving net unit growth of 7.5% [11] - Plans to welcome three new luxury and lifestyle hotels per week in 2025, with a focus on expanding in strategic markets [15] - The company aims for net unit growth solidly within the 6% to 7% range for the full year, supported by a strong development pipeline of over 510,000 rooms [25][63] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the intermediate-term outlook, citing a favorable regulatory environment and expected economic growth driven by significant investments across various industries [10][41] - The company anticipates RevPAR growth of flat to up 2% for the full year, with improving trends expected in the fourth quarter [26] - Management noted that the current operating environment is characterized by a thawing of the "wait and see" attitude among corporate clients, indicating potential growth in demand [39][108] Other Important Information - Hilton Honors membership grew to over 226 million, up 16% year-over-year, reflecting the strength of the company's global reach [16] - The company was named the most valuable hotel brand for the tenth consecutive year, highlighting its competitive position in the industry [17] Q&A Session Summary Question: Insights on different segments (leisure, business, group) - Management noted relative strength in leisure and weakness in business transient and group segments, with expectations for a more normalized fourth quarter [28][32] Question: Development trends in China amidst RevPAR declines - Management expects modest declines in China but remains optimistic about long-term development opportunities due to undersupply in the market [48][55] Question: Confidence in net unit growth - Management reinforced confidence in achieving 6% to 7% net unit growth, driven by strong conversion activity and a robust development pipeline [60][63] Question: Momentum in luxury segment and its implications - Management emphasized the importance of luxury and lifestyle brands for overall network effect and loyalty, while acknowledging they won't be the primary source of profitability [66][72] Question: Current environment for conversions and key money usage - Management reported that 33% of deals in the quarter were conversions, with expectations to increase to 40% for the year, while key money usage remains consistent [78][81] Question: Timing of non-RevPAR fees - Management clarified that the timing of termination fees and other non-RevPAR items was largely built into guidance, with some fees coming in earlier than expected [86][87]

Core Viewpoint - DexCom has faced significant challenges in the past year, including a 26% decline in stock price, but it has strong potential for growth in the next five years due to its market position and product offerings [1]. Group 1: Market Opportunity - DexCom specializes in continuous glucose monitoring (CGM) systems, which provide automatic and frequent blood sugar level measurements, leading to better health decisions for diabetes patients [2]. - The company has over 2.5 million customers globally as of 2024, indicating a strong installed base, yet there remains a substantial opportunity for growth in the CGM market [4]. - In the U.S., there are over 4.5 million diabetes patients on insulin therapy who are eligible for CGM but are not currently using it, highlighting a significant untapped market [5]. - The launch of Stelo, an over-the-counter CGM option, has expanded DexCom's addressable market to include diabetes patients not on insulin and those with prediabetes, where CGM penetration is currently low [6]. Group 2: Financial Performance and Valuation - Despite a decline in shares due to lower-than-expected revenue per customer, the company is positioned to improve its financial results as it continues to expand in the CGM market [9]. - DexCom's forward price-to-earnings ratio is 41.5, significantly higher than the healthcare sector average of 15.8, but this is on the lower end compared to its historical averages [10]. - The company has historically maintained high valuation metrics while delivering market-beating returns, suggesting potential for similar performance in the next five to ten years [12]. Group 3: Competitive Landscape and Ecosystem - DexCom competes with Abbott Laboratories in the CGM market, but there is ample opportunity for both companies to succeed given the large global market for CGM technology [12]. - The company benefits from a network effect, as its technology is compatible with various devices and applications, enhancing its ecosystem and attractiveness to developers [13]. - As more compatible technologies are launched, DexCom's appeal to patients is likely to increase, reinforcing its leadership position in the CGM market beyond the next five years [14].